Jiangxi Rimag Group Co (FRA:RD9) Other Current Receivables: €3.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RD9 Jiangxi Rimag Group Co Ltd FRA:RD9
14 GF Score
Price €0.50
! 6 Warning Signs
View Full Analysis

What is Jiangxi Rimag Group Co Other Current Receivables?

Jiangxi Rimag Group Co FRA:RD9 +3.42% 14 Other Current Receivables is €3.7 Mil as of Dec. 2025. GuruFocus rates FRA:RD9 with a GF Score™ of 14/100. The stock has 6 warning signs investors should review.

Jiangxi Rimag Group Co's Other Current Receivables for the quarter that ended in Dec. 2025 was €3.7 Mil.

Jiangxi Rimag Group Co's quarterly Other Current Receivables increased from Dec. 2024 (€1.47 Mil) to Jun. 2025 (€2.44 Mil) and increased from Jun. 2025 (€2.44 Mil) to Dec. 2025 (€3.68 Mil).

Jiangxi Rimag Group Co's annual Other Current Receivables increased from Dec. 2023 (€0.43 Mil) to Dec. 2024 (€1.47 Mil) and increased from Dec. 2024 (€1.47 Mil) to Dec. 2025 (€3.68 Mil).

Jiangxi Rimag Group Co Other Current Receivables Related Terms

Jiangxi Rimag Group Co Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Jiangxi Rimag Group Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Rimag Group Co Other Current Receivables Chart

Jiangxi Rimag Group Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
0.06 0.54 0.43 1.47 3.68

Jiangxi Rimag Group Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial 0.43 0.50 1.47 2.44 3.68
FRA:RD9
14GF Score
Jiangxi Rimag Group Co Ltd FRA:RD9
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangxi Rimag Group Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €3.7 Mil mean?
Jiangxi Rimag Group Co (FRA:RD9) has a Other Current Receivables of €3.7 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Jiangxi Rimag Group Co and its competitors.
Is Jiangxi Rimag Group Co's Other Current Receivables too high?
Jiangxi Rimag Group Co's current Other Current Receivables is €3.7 Mil. Overall, Jiangxi Rimag Group Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Rimag Group Co's Other Current Receivables compare to HCA and THC?
Jiangxi Rimag Group Co's Other Current Receivables of €3.7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Jiangxi Rimag Group Co and its competitors. Jiangxi Rimag Group Co's current Other Current Receivables is €3.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Rimag Group Co stock overvalued right now?
Jiangxi Rimag Group Co (FRA:RD9) has a current Other Current Receivables of €3.7 Mil. The current Other Current Receivables is €3.7 Mil. Jiangxi Rimag Group Co's overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Jiangxi Rimag Group Co (FRA:RD9), the current Other Current Receivables is €3.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jiangxi Rimag Group Co Business Description

Other Exchanges 02522:Hong Kong
Address Minzuyuan Road, Building 2, 2 Minzuyuan, 3rd Floor, Chaoyang District, Beijing, CHN
Jiangxi Rimag Group Co Ltd is a medical group specializing in medical imaging in China. The company generates revenue through these segments: Imaging Center Services, Imaging Solution Services, and Digital-intelligence services. The Imaging Center Services include examination and diagnostic services to patients and other healthcare consumers via its flagship imaging centers, such as MRI, CT, PET, X-ray, ultrasound and mammography. Majority of the revenue comes from Imaging center services. Geographically, the company operates in Chinese Mainland and Overseas (including Hong Kong and Macau). It generates maximum revenue from Chinese Mainland.
14GF Score

Get the complete analysis for FRA:RD9

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price